Postdoctoral Fellow, National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, Physician Fellow, Veterans Affairs Connecticut Healthcare System Yale University, Connecticut, US.
Healthc Policy. 2022 May;17(4):37-44. doi: 10.12927/hcpol.2022.26828.
In their piece, Herder and colleagues (2022) reveal the university origins of a key technology used in COVID-19 mRNA vaccines. They note that despite federal funding support and the university adopting "Global Access Principles," equitable, global access remains a challenge - in part due to the university's technology transfer practices. While for the past two decades university students have been successful in engaging institutional technology transfer offices in adopting similar access principles, implementation of these principles has been limited. This rejoinder points to the need for greater federal oversight and regulation to incentivize university action that enables equitable, global access.
在他们的文章中,赫尔德和同事们(2022 年)揭示了 COVID-19 mRNA 疫苗中使用的一项关键技术的大学起源。他们指出,尽管有联邦资金支持,而且大学采取了“全球准入原则”,但公平、全球准入仍然是一个挑战——部分原因是大学的技术转让做法。虽然在过去的二十年里,大学生已经成功地促使机构技术转让办公室采用类似的准入原则,但这些原则的实施受到了限制。这篇反驳文章指出,需要加强联邦监督和监管,激励大学采取行动,实现公平、全球准入。